Amphotericin B: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
==Category== | ==Category== | ||
Antifungal | |||
==US Brand Names== | ==US Brand Names== | ||
'''ABELCET<sup>®</sup>''' | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
Revision as of 15:21, 4 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
Antifungal
US Brand Names
ABELCET®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages